STAT

Opinion: Scribes can help transform health care by creating better clinical data

Scribes are the last piece in the 25-year puzzle to remake health care. The data they create will power analytics to overthrow the High Priests of Status Quo.

“Insurers, drug companies and large HMOs are mounting an extensive effort to use medical data to decide which treatments are best, which doctors are best and which plans keep people the healthiest.”

That quote, seemingly ripped from today’s headlines, was published in the New York Times 25 years ago this month. I know because I was featured in the story, which began my (mostly) friendly jousts with regulators, administrators, and even some physicians fighting externally driven change — a group I refer to as the High Priests of Status Quo.

Since that article appeared, health care has seriously lagged behind

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks